Evidence map›Paper›PMID 28090076›Full record

ReviewNature reviews. Microbiology2017

A journey into the brain: insight into how bacterial pathogens cross blood-brain barriers.

Mathieu Coureuil, Hervé Lécuyer, Sandrine Bourdoulous, Xavier Nassif

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Microbiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 146 papers.

0numbers the graph read from it
0cells of the map it votes in
146citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

146 citing papers in PubMed.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. mBio · 2026
    Article
  8. Infection and immunity · 2026
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Unraveling the oral microbiome's role in Alzheimer's disease: From pathophysiology to therapeutic potential.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Review
  16. Review
  17. Review
  18. Review
  19. Gut-derived bacterial vesicles carrying lipopolysaccharide promote microglia-mediated synaptic pruning.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  20. Article

86 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mathieu CoureuilInstitut National de la Santé et de la Recherche Médicale (INSERM) U1151, Institut Necker-Enfants Malades, 14 Rue Maria Helena Vieira da Silva, 75014 Paris, France.
Hervé LécuyerInstitut National de la Santé et de la Recherche Médicale (INSERM) U1151, Institut Necker-Enfants Malades, 14 Rue Maria Helena Vieira da Silva, 75014 Paris, France.
Sandrine BourdoulousFaculté de Médecine, Université Paris Descartes, 75014 Paris, France.
Xavier NassifInstitut National de la Santé et de la Recherche Médicale (INSERM) U1151, Institut Necker-Enfants Malades, 14 Rue Maria Helena Vieira da Silva, 75014 Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The blood-brain barrier, which is one of the tightest barriers in the body, protects the brain from insults, such as infections. Indeed, only a few of the numerous blood-borne bacteria can cross the blood-brain barrier to cause meningitis. In this Review, we focus on invasive extracellular pathogens, such as Neisseria meningitidis, Streptococcus pneumoniae, group B Streptococcus and Escherichia coli, to review the obstacles that bacteria have to overcome in order to invade the meninges from the bloodstream, and the specific skills they have developed to bypass the blood-brain barrier. The medical importance of understanding how these barriers can be circumvented is underlined by the fact that we need to improve drug delivery into the brain.

Indexed as

Blood-Brain BarrierDrug Delivery SystemsEscherichia coliHumansMeningesMeningitis, BacterialNeisseria meningitidisStreptococcus agalactiaeStreptococcus pneumoniae

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.